RxDoctor Payments Data

Thomas George, MD

Hospitalist · Fort Atkinson, WINPI 1922448018

Payments from drug & device makers

$351in general payments, 2019–2025

Across 9 payments — averaging $38.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Madrigal Pharmaceuticals$149
  • Biosense Webster, Inc.$60
  • Pfizer$41
  • Axsome Therapeutics, Inc.$26
  • Bayer$21
  • Exact Sciences$19
  • plus $35 from 2 others

What the payments were for

  • Food & beverage$351100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$351 in reported general payments places this provider in the 85th percentile of 679 hospitalist providers in Wisconsin.

See all hospitalist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$50,126
Medicare patients
226
Services billed
520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban30$10,908
Potassium Chloride17$3,810
CefuroximeCefuroxime Axetil33$583
Methenamine Hippurate18$556
Calcium Acetate15$483
Gabapentin40$415
Amlodipine Besylate40$276
Famotidine27$232
Oxybutynin Chloride14$227
ClopidogrelClopidogrel Bisulfate24$221
Atorvastatin Calcium17$196
Pantoprazole Sodium18$174
Azithromycin19$160
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$157
Prednisone24$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$41$10,90830 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 679 hospitalist providers in Wisconsin.

Other hospitalist in Fort Atkinson

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →